Adaptogenics Health Corp. is advancing a strategy to evaluate proprietary peptide and small molecule opportunities focused on metabolic health, muscle preservation, mitochondrial biology and inflammation. Through its existing health products business, the Company is also evaluating GLP 1 companion products intended to support nutritional health, muscle function and other common challenges associated with medically induced weight loss.